{
    "code": "52026565",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026565",
    "time": "2021-01-01 04:16:29",
    "許可證字號": "衛部藥輸字第026565號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "109\/11\/02",
    "發證日期": "104\/11\/02",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202656501",
    "中文品名": "骨密妥發泡錠",
    "英文品名": "Binosto (alendronate sodium) Effervescent Tablets for oral solution, 70 mg",
    "適應症": "停經婦女骨質疏鬆症之治療。治療男性骨質疏鬆症，以增加骨密度。",
    "劑型": "114發泡錠",
    "包裝": "2-1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ALENDRONATE SODIUM TRIHYDRATE",
    "限制項目": "02輸　入 26監視期滿新藥",
    "申請商名稱": "6201170467  亞博實業股份有限公司",
    "申請商地址": "臺北市信義區永吉路168號12樓之2",
    "主製造廠": [
        {
            "製造廠名稱": "FCH0303000  SWISSCO SERVICES AG",
            "製造廠廠址": "BAHNHOFSTRASSE 14, 4334 SISSELN, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200036530",
            "成分名稱": "ALENDRONATE SODIUM TRIHYDRATE",
            "含量描述": "Sodium alendronate trihydrate (micronised) (equivalent to 70mg of alendronate acid)",
            "含量": "91.3700000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "520265650001-104-11-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026565&Seq=001&Type=9"
        },
        {
            "title": "520265650002-104-11-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026565&Seq=001&Type=8"
        }
    ]
}